Pura Vida Investments, LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Pura Vida Investments, LLC disclosed 8 US equity positions worth $13.7m in its Q1 2025 13F filing. The largest position was BBNX at 38.4% of the reported book, followed by IMDX and ESTA. Against the Q4 2024 filing, it opened 3 new positions, added to 1 and reduced 2 among the top 8 holdings.
What did Pura Vida Investments, LLC own in Q1 2025? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BBNX BETA BIONICS INC | Healthcare | 38.4% | $5.3m | 429,120 | – | new |
| 2 | IMDX ONCOCYTE CORP | 21.2% | $2.9m | 947,134 | 45% | added | |
| 3 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 13.4% | $1.8m | 45,000 | -60% | reduced |
| 4 | NSPR INSPIREMD INC | 8.9% | $1.2m | 450,517 | 0% | held | |
| 5 | KESTRA MED TECHNOLOGIES LTD | 7.3% | $996.8k | 40,000 | – | new | |
| 6 | OM OUTSET MED INC | 5.7% | $783.4k | 5,000 | – | new | |
| 7 | MGX METAGENOMI INC | 2.6% | $359.6k | 264,391 | 0% | held | |
| 8 | NTRA NATERA INC | Healthcare | 2.6% | $353.5k | 2,500 | -50% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.